Par Health Recalls 22 Argatroban Lots Over Particulate Matter
Rochester, Mich. – October 13, 2026 -- Par Health is recalling 22 lots of Argatroban Injection 250 mg/2.5 mL (100 mg/mL) to the hospital/user level after detecting particulate matter in certain lots.
Particulates include cellulose, plastics and stopper material
The company identified the contaminants as cellulose, polystyrene, polyethylene terephthalate, stopper material, and possibly stainless steel. Par Health states that administering product containing particulate matter has a reasonable probability of causing life-threatening adverse health consequences.
The listed risks are pulmonary emboli, occlusions of other blood vessels that can lead to tissue death and possible organ damage, and inflammation of vein walls that may lead to clotting. To date, Par Health has received no reports of adverse events related to the recall.